SECONDARY ANALYSES IN THE ATRIAL CARDIOPATHY AND ANTITHROMBOTIC DRUGS IN PREVENTION AFTER CRYPTOGENIC STROKE (ARCADIA) RANDOMIZED TRIAL

被引：0

作者：

Tirschwell, D. ^{[1
]}

Longstreth, W. T., Jr. ^{[1
]}

Kamel, H. ^{[2
]}

Kronmal, R. ^{[3
]}

Marshall, R. ^{[4
]}

Broderick, J. ^{[5
]}

Garcia, R. Aragon ^{[4
]}

Plummer, P. ^{[5
]}

Pauls, Q. ^{[6
]}

Dillon, C. ^{[6
]}

Di Tullio, M. ^{[7
]}

Gladstone, D. ^{[8
]}

Healey, J. ^{[9
]}

Janis, S. ^{[10
]}

Elkind, M. ^{[4
]}

机构：

[1] Univ Washington, Harborview Med Ctr, Neurol, Box 359775, Seattle, WA USA

[2] Cornell Univ, Neurol, New York, NY USA

[3] Univ Washington, Biostat, Seattle, WA USA

[4] Columbia Univ, Neurol, New York, NY USA

[5] Univ Cincinnati, Neurol & Rehabil Med, Cincinnati, OH USA

[6] Med Univ South Carolina, Publ Hlth Sci, Charleston, SC USA

[7] Columbia Univ, Cardiol, New York, NY USA

[8] Univ Toronto, Sunnybrook Res Inst, Sunnybrook Hlth Sci Ctr, Med Neurol, Toronto, ON, Canada

[9] McMaster Univ, Med, Toronto, ON, Canada

[10] NINDS, NIH, Bethesda, MD USA

来源：

INTERNATIONAL JOURNAL OF STROKE | 2023年 / 18卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

LBO015

引用

页码：426 / 427

页数：2

共 50 条

[31] Late Detection of Atrial Fibrillation after Stroke: Implications for the Secondary Prevention
Tanislav, Christian
Kostev, Karel
EUROPEAN NEUROLOGY, 2019, 81 (5-6) : 262 - 269
[32] Transient ischemic attacks in patients with atrial fibrillation - Implications for secondary prevention: The European Atrial Fibrillation Trial and Stroke Prevention in Atrial Fibrillation III Trial
Hart, RG
Pearce, LA
Koudstaal, PJ
STROKE, 2004, 35 (04) : 948 - 951
[33] PFO closure for prevention of recurrent stroke in patients after cryptogenic stroke: The imperative of completing randomized controlled trials
Kaplan, Aaron V.
Lukovits, Timothy G.
Robb, John F.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 69 (01) : 6 - 8
[34] Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation - A multicenter, prospective, randomized trial
Yamaguchi, T
STROKE, 2000, 31 (04) : 817 - 821
[35] DESIGN OF A MULTICENTER RANDOMIZED TRIAL FOR THE STROKE PREVENTION IN ATRIAL-FIBRILLATION STUDY
MCBRIDE, R
STROKE, 1990, 21 (04) : 538 - 545
[36] Dual site atrial pacing for atrial fibrillation prevention: Insights from the DAPPAF trial secondary analyses
Saksena, S
Prakash, A
Ziegler, PD
Friedman, PA
Wyse, DG
CIRCULATION, 2001, 104 (17) : 658 - 658
[37] EFFECTIVENESS AND SAFETY OF ANTITHROMBOTIC DRUGS USED FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION (ESC-FA STUDY)
Giner-Soriano, M.
Morros, R.
Vedia Urgell, C.
Roso-Llorach, A.
Castells, X.
Capella, D.
CLINICAL THERAPEUTICS, 2015, 37 (08) : E12 - E12
[38] Antithrombotic strategies after cryptogenic stroke: a systematic review, pairwise, and network meta-analysis of randomized controlled trials
Abuelazm, M.
Mazen, A. M.
Ali, H. T.
Nazir, A.
Ayyad, M.
Ramadan, S.
Tanashat, M.
Abouzid, M.
Abdelazeem, B.
EUROPEAN HEART JOURNAL, 2024, 45
[39] Antithrombotic strategies after cryptogenic stroke: a systematic review, pairwise, and network meta-analysis of randomized controlled trials
Abuelazm, M.
Mazen, A. M.
Ali, H. T.
Nazir, A.
Ayyad, M.
Ramadan, S.
Tanashat, M.
Abouzid, M.
Abdelazeem, B.
EUROPEAN HEART JOURNAL, 2024, 45
[40] Novel Anticoagulants in Secondary Stroke Prevention after TIA or Minor Stroke in Patients with Atrial Fibrillation
Diener, Hans-Christoph
CEREBROVASCULAR DISEASES, 2013, 36 : 8 - 8

← 1 2 3 4 5 →